Status:
ACTIVE_NOT_RECRUITING
Left Bundle Branch Area Pacing in Patients With Heart Failure
Lead Sponsor:
National Research Center for Cardiac Surgery, Kazakhstan
Conditions:
Heart Failure With Reduced Ejection Fraction
Left Bundle Branch Area Pacing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The relevance of Left Bundle Branch Pacing (LBBP) lies in its potential as a promising treatment option for patients with heart failure and left bundle branch block. LBBP aims to restore the normal ph...
Detailed Description
The aim The aim of Left Bundle Branch Pacing (LBBP) research is to assess its effectiveness in improving the contractile capacity of the left ventricular myocardium. The objectives are as follows * T...
Eligibility Criteria
Inclusion
- Male or female ≥ 18 years of age at Visit 1.
- Patients with complete left bundle branch block, QRS duration greater than 130 ms, left ventricular ejection fraction (LVEF) less than 35%, and New York Heart Association (NYHA) functional class 2-3, who have been ineffective on optimal medical therapy for at least 3 months.
- Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
Exclusion
- Pregnancy.
- Psychic disturbances.
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data - life expectancy less than 1 year.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06488989
Start Date
June 1 2024
End Date
June 1 2026
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CF UMC
Astana, Kazakhstan, 010000